{"id":"W2889881016","doi":"10.1200/jco.2017.35.15_suppl.tps5095","title":"Abiraterone +/- cabazitaxel in defining complete response in prostatectomy (ACDC-RP) trial.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; University Health Network; University of Toronto; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Cabazitaxel; Medicine; Prostate cancer; Clinical endpoint; Prostatectomy; Urology; Oncology; Prednisone; Docetaxel; Internal medicine; Androgen deprivation therapy; Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001672058,0.001164772,0.001424534,0.0003097485,0.0002391839,0.0009997502,0.0006846544,0.0007715652,0.005526439],"category_scores_gemma":[0.0009327826,0.0004108636,0.0008853919,0.000301559,0.0006784316,0.0005699818,0.000324018,0.002116358,0.000760151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005893091,"about_ca_system_score_gemma":0.0009918833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008605283,"about_ca_topic_score_gemma":0.003451904,"domain_scores_codex":[0.9995247,0.0002647488,0.00002229458,0.00007217695,0.00005386423,0.00006225133],"domain_scores_gemma":[0.9995016,0.0001041408,0.0001297407,0.0000395781,0.00002175135,0.0002031423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9351333,0.00445056,0.001155435,0.001119763,0.0008563736,0.00007554185,0.00005595268,0.001398081,0.004960458,0.0003496789,0.002208324,0.04823655],"study_design_scores_gemma":[0.8921509,0.0996325,0.004010911,0.00007700126,0.000484383,0.0001576559,0.00002467237,0.0008290456,0.0006225775,0.0002484247,0.001745149,0.00001687974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790356,0.009353415,0.0006403119,0.0008582373,0.0005311572,0.003222423,0.001594612,0.0001950405,0.004569341],"genre_scores_gemma":[0.9875733,0.003171431,0.001219759,0.0008221599,0.000360289,0.001987134,0.001286699,0.00001750233,0.003561727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005526439,"threshold_uncertainty_score":0.01848781,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3262107862489707,"score_gpt":0.5600936919070783,"score_spread":0.2338829056581075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}